
By targeting the specific pathological function of the ‘culprit’ molecule rather than inhibiting its gene expression, new approach facilitates development of cancer drugs with fewer side effects.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/TK1pH7iaZoU/150213081517.htm